ASH 2015: New targeted therapies for haematological malignancies

Study underscores promise of targeted therapies as first-line approach for patients with chronic lymphocytic leukaemia

First targeted therapy for multiple myeloma effective against hard-to-treat disease

First targeted therapy for genetically defined subset with acute myeloid leukaemia significantly improves survival

Variants for increased risk of osteonecrosis in paediatric acute lymphocytic leukaemia identified

Guidance for anticoagulation management in the setting of thrombocytopenia in cancer patients

Tosedostat for elderly acute myeloid leukaemia

Children most at risk of over-reporting adherence to at-home chemotherapy regimen

Researchers identify children most at risk of over-reporting adherence to at-home chemotherapy regimen

Research provides guidance for anticoagulation management in the setting of thrombocytopenia in cancer patients

Promising new strategy for treating children with acute lymphocytic leukaemia

Comment: Classification system based on cytogenetics and treatment response identifies leukaemia patients with high-risk clinical features